Capstone Therapeutics (CAPS) is a company that is looking to make an entry into a billion dollar market come 2011. They have a pending Phase II data for their novel drug AVX100 for Dermal Scarring.
Article source: http://seekingalpha.com/article/241102-capstone-therapeutics-looking-to-capitalize-on-the-growing-dermal-market?source=feed
Read more ...